Global Unit Dose Manufacturing Market Report 2024: Growth Rate, Major Segments And Regions

The Unit Dose Manufacturing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Unit Dose Manufacturing Market:
https://www.thebusinessresearchcompany.com/report/unit-dose-manufacturing-global-market-report

According to The Business Research Company’s Unit Dose Manufacturing Global Market Report 2024, The unit dose manufacturing market size has grown exponentially in recent years. It will grow from $27.36 billion in 2023 to $33.16 billion in 2024 at a compound annual growth rate (CAGR) of 21.2%. The growth in the historic period can be attributed to traditional pharmaceutical manufacturing practices, regulatory developments in drug packaging, rise in demand for personalized medicine, growth of the aging population, increased prevalence of chronic diseases.

The unit dose manufacturing market size is expected to see exponential growth in the next few years. It will grow to $71.83 billion in 2028 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to adoption of industry 4.0 in pharmaceutical manufacturing, emphasis on personalized and precision medicine, regulatory focus on drug safety and efficacy, expansion of pharmaceutical outsourcing, growing demand for patient-centric drug delivery. Major trends in the forecast period include implementation of advanced automation in unit dose manufacturing, integration of iot in pharmaceutical packaging, customization of unit dose packaging for specific drugs, adoption of sustainable and eco-friendly packaging materials, growth of 3d printing in personalized drug manufacturing.

The rise in healthcare spending is expected to propel the growth of the unit dose manufacturing market going forward. Health spending refers to all costs associated with providing health services, family planning activities, nutrition programs, and emergency help focusing on health. Increasing healthcare expenditure would help advance and develop various health-related services, including unit dose manufacturing, which will support the growth of the unit dose manufacturing market. For instance, in February 2023, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, healthcare spending in the United States increased 2.7 % to $12,914 per person in 2021, or $4.3 trillion. Further, spending on healthcare accounted for 18.3 % of the country’s GDP. Therefore, the rise in healthcare spending is driving the growth of the unit dose manufacturing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12215&type=smp

The unit dose manufacturing market covered in this report is segmented –

1) By Product: Liquid Unit Dose, Solid Unit Dose, Other Products
2) By Sourcing: In-House, Outsourcing
3) By End-User: Independent Pharmacies, Long Term Care Facility, Hospitals, Other End-Users

Product innovations are a key trend gaining popularity in the unit-dose manufacturing market. Major companies operating in the unit dose manufacturing market are developing innovative products to sustain their position in the market. For instance, in March 2021, Ritedose Corporation, a US-based contract pharmaceutical manufacturer, launched Succinylcholine Chloride Injection 200 mg/10 mL (20 mg/mL), a new unit-dose syringe product. It is already diluted, labeled with warnings, color-coded to ASTM drug class standards, and prepared for administration in acute care settings. It can be stored at room temperature. Prefilled syringes’ predetermined concentration eliminates the need for in-hospital compounding and lessens the possibility that patients will get dosages below or above therapeutic levels.

The unit dose manufacturing market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis